What is the ticker symbol for Repligen Corporation?

The ticker symbol for Repligen Corporation is NASDAQ:RGEN

Does Repligen Corporation pay dividends?

No, Repligen Corporation does not pay dividends

What sector is Repligen Corporation in?

Repligen Corporation is in the Healthcare sector

What industry is Repligen Corporation in?

Repligen Corporation is in the Medical Instruments & Supplies industry

What country is Repligen Corporation based in?

Repligen Corporation is headquartered in United States

When did Repligen Corporation go public?

Repligen Corporation initial public offering (IPO) was on April 29, 1986

Is Repligen Corporation in the S&P 500?

No, Repligen Corporation is not included in the S&P 500 index

Is Repligen Corporation in the NASDAQ 100?

No, Repligen Corporation is not included in the NASDAQ 100 index

Is Repligen Corporation in the Dow Jones?

No, Repligen Corporation is not included in the Dow Jones index

When was Repligen Corporation last earnings report?

Repligen Corporation's most recent earnings report was on July 28, 2026

When does Repligen Corporation report earnings?

The next expected earnings date for Repligen Corporation is October 27, 2026

RGEN Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, RGEN price is $176.43, up +0.58% on October 19, 2026
Current Price All-Time High: RGEN price is currently -46.10% below its historical high of $327.32 set on September 23, 2021
Market Cap: RGEN current market cap is $11B, up +30.42% over the past 365 days
PE Ratio: RGEN current PE ratio is 240.47
Revenue: RGEN current annual revenue is $738.26M, up +16.36% year-over-year
Next Earnings: The next earnings release for RGEN is on October 27, 2026

Profile

Company profile for Repligen Corporation (RGEN)
Metric	Value
Full Name	Repligen Corporation
Ticker	NASDAQ: RGEN
Exchange	NASDAQ
Sector	Healthcare
Industry	Medical Instruments & Supplies
Country	United States
IPO	Apr 29, 1986
Indexes	Not included
Website	repligen.com
Employees	1,778

Key Metrics

Repligen Corporation Key Details
Metric	Value	Date
Price	$176.43	Oct 19, 26
Price, 1D Change	+0.58%	Oct 19, 26
Market Cap	$11B	Oct 19, 26
	-	Oct 19, 26
PE Ratio	240.47	Oct 19, 26
Beta	1.19	Oct 19, 26
Revenue	$738.26M	Dec 31, 25
Revenue, 1Y Change	+16.36%	Dec 31, 25
EPS	$0.86	Dec 31, 25
EPS, 1Y Change	+289.52%	Dec 31, 25

Events

Repligen Corporation Events
Metric	Value	Date
Next Earnings		Oct 27, 26
Last Qtr. Earnings		Jul 28, 26
Last Ann. Earnings		Feb 24, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	N/A	N/A
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

RGEN Estimates
Metric	Value	Date
EPS	$0.86	Dec 31, 25
EPS Estimate	$2.06	N/A
EPS Est. Change	+138.85%	N/A
Revenue	$738.26M	Dec 31, 25
Revenue Estimate	$833.30M	N/A
Revenue Est. Change	+12.87%	N/A
Current Price	$176.43	Oct 19, 26
Price Target	$200.00	-
Price Tgt. Change	+13.36%	-

🔒 Log In To Unlock Full Data

EPS

RGEN EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	$1.53	-$0.46	-129.72%
2025	$1.67	$0.86	-48.18%
2026	$2.06	N/A	+138.85%
2027	$2.67	N/A	+208.85%

Revenue

RGEN revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$634.06M	$634.44M	+0.06%
2025	$732.50M	$738.26M	+0.79%
2026	$833.30M	N/A	+12.87%
2027	$1.08B	N/A	+46.37%

🔒 Log In To Unlock Full Data

Performance

RGEN Performance
Metric	Value	Date
Price, 1Y	+15.62%	Oct 19, 26
Price, 3Y	+20.61%	Oct 19, 26
Market Cap, 1Y	+30.42%	Oct 19, 26
Market Cap, 3Y	+37.30%	Oct 19, 26
Revenue, 1Y	+16.36%	Dec 31, 25
Revenue, 3Y	-7.89%	Dec 31, 25
EPS, 1Y	+289.52%	Dec 31, 25
EPS, 3Y	-73.29%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

RGEN Technical Indicators
Metric	Value	Date
Current Price	$176.43	Oct 19, 26
SMA 200	$144.19	Oct 19, 26
SMA 50	$176.03	Oct 19, 26
EMA 200	$151.60	Oct 19, 26
EMA 50	$172.24	Oct 19, 26
MACD	$0.25	Oct 19, 26
Beta	1.19	Oct 19, 26
ATR	$8.51	Oct 19, 26
14-Day RSI	49.53	Oct 19, 26
10-Day Volatility	66.22%	Oct 19, 26

Dividends

RGEN Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Oct 19, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

RGEN Income & Profitability
Metric	Value	Date
Revenue	$738.26M	Dec 31, 25
EPS	$0.86	Dec 31, 25
Gross Profit	$347.62M	Dec 31, 25
Gross Margin	47.50%	Dec 31, 25
Operating Income	$59.58M	Dec 31, 25
Operating Margin	8.07%	Dec 31, 25
Net Income	$48.89M	Dec 31, 25
Net Margin	6.62%	Dec 31, 25
EBITDA	$138.32M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

RGEN Financial Health
Metric	Value	Date
Debt To Equity	0.33	Dec 31, 25
	8.37	Dec 31, 25
	7.12	Dec 31, 25
	-	Dec 31, 25
	7	Jun 30, 26
	8.91	Oct 19, 26

Valuations

RGEN Valuations
Metric	Value	Date
PE Ratio	240.47	Oct 19, 26
	14.27	Oct 19, 26
	5.30	Oct 19, 26
	64.12	Oct 19, 26
	-	N/A

Balance Sheet

RGEN Balance Sheet
Metric	Value	Date
Book Value	$2.11B	Dec 31, 25
	$767.63M	Dec 31, 25
	$2.95B	Dec 31, 25
	$1.14B	Dec 31, 25
	$843.57M	Dec 31, 25
	$135.83M	Dec 31, 25
Total Debt	$689.95M	Dec 31, 25
	$21.56M	Dec 31, 25
	$30.01M	Dec 31, 25

Expenses

RGEN Expenses
Metric	Value	Date
	$689.36M	Dec 31, 25
	$288.05M	Dec 31, 25
	$390.63M	Dec 31, 25
	$0.00	Dec 31, 25
	$96.96M	Dec 31, 25
	$0.00	Dec 31, 25
	$13.49M	Dec 31, 25

Cash Flow

RGEN Cash Flow
Metric	Value	Date
	$117.42M	Dec 31, 25
	-$298.47M	Dec 31, 25
	-$15.21M	Dec 31, 25
Capex	$25.73M	Dec 31, 25
	$91.69M	Dec 31, 25

Recent analyst updates

RGEN Recent analyst updates
Metric	Value	Date
Barclays	→	Oct 7, 26
UBS	→	Sep 9, 26
Wells Fargo	→	Jul 30, 26
JP Morgan	→	Jul 29, 26
Benchmark	→	Jul 7, 26
Evercore ISI Group	→	Jul 6, 26
HSBC	→	Jun 3, 26
JP Morgan	→	May 6, 26
Barclays	→	May 6, 26
Canaccord Genuity	→	Apr 20, 26

Analyst sentiment

Institutional ownership

No data

Screeners with RGEN

FAQ

What is the ticker symbol for Repligen Corporation?: The ticker symbol for Repligen Corporation is NASDAQ:RGEN
Does Repligen Corporation pay dividends?: No, Repligen Corporation does not pay dividends
What sector is Repligen Corporation in?: Repligen Corporation is in the Healthcare sector
What industry is Repligen Corporation in?: Repligen Corporation is in the Medical Instruments & Supplies industry
What country is Repligen Corporation based in?: Repligen Corporation is headquartered in United States
When did Repligen Corporation go public?: Repligen Corporation initial public offering (IPO) was on April 29, 1986
Is Repligen Corporation in the S&P 500?: No, Repligen Corporation is not included in the S&P 500 index
Is Repligen Corporation in the NASDAQ 100?: No, Repligen Corporation is not included in the NASDAQ 100 index
Is Repligen Corporation in the Dow Jones?: No, Repligen Corporation is not included in the Dow Jones index
When was Repligen Corporation last earnings report?: Repligen Corporation's most recent earnings report was on July 28, 2026
When does Repligen Corporation report earnings?: The next expected earnings date for Repligen Corporation is October 27, 2026

Data Sources & References

RGEN Official Website www.repligen.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/730272/000119312526076528/0001193125-26-076528-index.htm
RGEN Profile on Yahoo Finance finance.yahoo.com/quote/RGEN
RGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgen